NHS National Framework for the supply of Ustekinumab - 1 September 2024

A Contract Award Notice
by NHS ENGLAND

Source
Find a Tender
Type
Framework (Supply)
Duration
2 year (est.)
Value
£284M
Sector
HEALTH
Published
12 Sep 2024
Delivery
01 Sep 2024 to 31 Aug 2026 (est.)
Deadline
n/a

Concepts

Location

Please refer to Document No. 10 in the ITO Documents for the list of Purchasing Points

Geochart for 2 buyers and 12 suppliers

2 buyers

6 suppliers

Description

Project title: NHS National Framework for the supply of Ustekinumab 1 September 2024Offer reference number: CM/TNS/24/5711CM/TNS/24/5711/01 - NHS Framework for the supply of Ustekinumab - London & South of England. Period of framework: 1 September 2024 to 31 August 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.CM/TNS/24/5711/02 - NHS Framework for the supply of Ustekinumab - North of England and Midlands & East. Period of framework: 1 September 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England

Lot Division

1 CM/TNS/24/5711/01 - NHS Framework for the supply of Ustekinumab - London & South

CM/TNS/24/5711/01 - NHS Framework for the supply of Ustekinumab - London & South of England. Period of framework: 1 September 2024 to 31 August 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.
2 CM/TNS/24/5711/02 - NHS Framework for the supply of Ustekinumab - North & MAE

CM/TNS/24/5711/02 - NHS Framework for the supply of Ustekinumab - North of England and Midlands & East. Period of framework: 1 September 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.

Award Detail

1 Amgen (Cambridge)
  • NHS Framework for the supply of Ustekinumab - London & South of England
  • Num offers: 6
  • Value: £1
2 Sandoz (Surrey)
  • NHS Framework for the supply of Ustekinumab - London & South of England
  • Num offers: 6
  • Value: £1
  • Contractor is an SME.
3 Thornton & Ross (Huddersfield)
  • NHS Framework for the supply of Ustekinumab - London & South of England
  • Num offers: 6
  • Value: £1
4 Celltrion Healthcare (Slough)
  • NHS Framework for the supply of Ustekinumab - London & South of England
  • Num offers: 6
  • Value: £1
5 Janssen Cilag (Highwycombe)
  • NHS Framework for the supply of Ustekinumab - London & South of England
  • Num offers: 6
  • Value: £1
6 Accord (Devon)
  • NHS Framework for the supply of Ustekinumab - London & South of England
  • Num offers: 6
  • Value: £1
7 Amgen (Cambridge)
  • NHS Framework for the supply of Ustekinumab - North of England and Midlands & East
  • Num offers: 6
  • Value: £1
8 Sandoz (Surrey)
  • NHS Framework for the supply of Ustekinumab - North of England and Midlands & East
  • Num offers: 6
  • Value: £1
  • Contractor is an SME.
9 Thornton & Ross (Huddersfield)
  • NHS Framework for the supply of Ustekinumab - North of England and Midlands & East
  • Num offers: 6
  • Value: £1
10 Celltrion Healthcare (Slough)
  • NHS Framework for the supply of Ustekinumab - North of England and Midlands & East
  • Num offers: 6
  • Value: £1
11 Janssen Cilag (Highwycombe)
  • NHS Framework for the supply of Ustekinumab - North of England and Midlands & East
  • Num offers: 6
  • Value: £1
12 Accord (Devon)
  • NHS Framework for the supply of Ustekinumab - North of England and Midlands & East
  • Num offers: 6
  • Value: £1

Renewal Options

Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Award Criteria

PRICE _

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Options are available.
  • Award on basis of price.

Reference

Domains